Huihui Chen

Changsha, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Clonally expanded HSP-specific T cells contribute to glaucomatous neurodegeneration via the mTORC1 pathway.

Clonally expanded HSP-specific T cells contribute to glaucomatous neurodegeneration via the mTORC1 pathway.

Journal: Journal of neuroinflammation
Published: September 10, 2025

Loss of Triggering Receptor Expressed on Myeloid Cells 2 Impairs Microglial Function and Exacerbates Retinal Neurodegeneration in Glaucoma.

Loss of Triggering Receptor Expressed on Myeloid Cells 2 Impairs Microglial Function and Exacerbates Retinal Neurodegeneration in Glaucoma.

Journal: The American journal of pathology
Published: August 23, 2025

Microglia crosstalk with T cells in neurodegenerative diseases: pathogenesis and treatment targets.

Microglia crosstalk with T cells in neurodegenerative diseases: pathogenesis and treatment targets.

Journal: International immunopharmacology
Published: August 12, 2025

Tunable and Stable Triplex DNA Structure for Surface Plasmon Resonance Detection of UV-Induced DNA Damage.

Tunable and Stable Triplex DNA Structure for Surface Plasmon Resonance Detection of UV-Induced DNA Damage.

Journal: ACS sensors
Published: May 29, 2025

B-cell depletion therapy reduces retinal inflammation in experimental autoimmune uveoretinitis.

B-cell depletion therapy reduces retinal inflammation in experimental autoimmune uveoretinitis.

Journal: International immunopharmacology
Published: December 28, 2024

Zotarolimus alleviates post-trabeculectomy fibrosis via dual functions of anti-inflammation and regulating AMPK/mTOR axis.

Zotarolimus alleviates post-trabeculectomy fibrosis via dual functions of anti-inflammation and regulating AMPK/mTOR axis.

Journal: International immunopharmacology
Published: July 24, 2024

Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development.

Dietary sodium modulates mTORC1-dependent trained immunity in macrophages to accelerate CKD development.

Journal: Biochemical pharmacology
Published: May 24, 2024

A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney disease.

A potential defensive role of TIM-3 on T lymphocytes in the inflammatory involvement of diabetic kidney disease.

Journal: Frontiers in immunology
Published: January 04, 2024

Unravelling T-cell dynamics and immune responses in initial and recurrent uveitis.

Unravelling T-cell dynamics and immune responses in initial and recurrent uveitis.

Journal: Scandinavian journal of immunology
Published: January 04, 2024

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China.

Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China.

Journal: Frontiers in pharmacology
Published: October 08, 2023

The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease.

The kinetics of mTORC1 activation associates with FOXP3 expression pattern of CD4+ T cells and outcome of steroid-sensitive minimal change disease.

Journal: International immunopharmacology
Published: June 14, 2023

T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases.

T-cell immunoglobulin and mucin-domain containing-3 (TIM-3): Solving a key puzzle in autoimmune diseases.

Journal: International immunopharmacology
Published: May 13, 2023
Showing 1-12 of 18

Last Updated: 09/26/2026